Timeline milestone
A Patient's Immune Cells Become an Approved Cancer Vaccine
From How Cancer Treatment Became Personal: From Chemotherapy to Precision Immunotherapy
-
Regulatory
A Patient's Immune Cells Become an Approved Cancer Vaccine
Sipuleucel-T became the first approved therapeutic cancer vaccine, using a patient's own immune cells to stimulate an attack on prostate cancer.
The treatment personalized manufacturing around each patient rather than creating one identical product for everyone. Its benefit was modest and limited to a defined setting, but it demonstrated that an individualized immune product could be manufactured, regulated and delivered as medicine.
Sources & references 1 source
